Sally Egginton

Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study

Michael Gold, Claire Alderton, Marina Zvartau‐Hind et al. · Dementia and Geriatric Cognitive Disorders · 2010 · 351 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea

Fengchun Zhang, Sang‐Cheol Bae, Damon Bass et al. · Annals of the Rheumatic Diseases · 2018 · 295 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy and safety of intravenous belimumab in Japanese patients with systemic lupus erythematosus: A subgroup analysis of a phase 3 randomized placebo-controlled trial

Yoshiya Tanaka, Damon Bass, Myron Chu et al. · Modern Rheumatology · 2018 · 23 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Organ system improvements in Japanese patients with systemic lupus erythematosus treated with belimumab: A subgroup analysis from a phase 3 randomized placebo-controlled trial

Yoshiya Tanaka, Damon Bass, Myron Chu et al. · Modern Rheumatology · 2019 · 13 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13